Ronen Ben‐Ami
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 10
-
- Antifungal resistance and susceptibility 63
- SARS-CoV-2 and COVID-19 Research 11
- Co-authors
- Dimitrios P. KontoyiannisRussell E. LewisYehuda CarmeliShiri Navon‐VeneziaDavid A. SchwartzMitchell J. SchwaberKonstantinos LeventakosMichael Giladi
- Journals
- Clinical Infectious Diseases (8 papers)Mycoses (7 papers)Clinical Microbiology and Infection (7 papers)Journal of Fungi (7 papers)Antimicrobial Agents and Chemotherapy (7 papers)
- Partner nations
- IsraelUnited StatesChina
In The Last Decade
Ronen Ben‐Ami
153 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Applied Microbiology and Biotechnology 523
- Molecular Medicine 1.1k
- Infectious Diseases 2.8k
- Endocrinology 405
- Epidemiology 2.6k
Countries citing papers authored by Ronen Ben‐Ami
This map shows the geographic impact of Ronen Ben‐Ami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronen Ben‐Ami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronen Ben‐Ami more than expected).
Fields of papers citing papers by Ronen Ben‐Ami
This network shows the impact of papers produced by Ronen Ben‐Ami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronen Ben‐Ami. The network helps show where Ronen Ben‐Ami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ronen Ben‐Ami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 12 | |
| 10 | 2020 | 18 | |
| 11 | 2017 | 9 | |
| 12 | 2014 | 8 | |
| 13 | 2014 | 4 | |
| 14 | 2013 | 191 | |
| 15 | 2010 | 16 | |
| 16 | 2009 | 94 | |
| 17 | 2009 | 52 | |
| 18 | A Murine Model of Myocutaneous Invasive Aspergillosis | 2008 | 1 |
| 19 | 2006 | 328 | |
| 20 | 2002 | 15 |
About Ronen Ben‐Ami
Ronen Ben‐Ami is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Microbiology, Epidemiology and Molecular Medicine, having authored 158 papers that have together received 5.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (63 papers), Fungal Infections and Studies (52 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Antibiotic Resistance in Bacteria (11 papers), Infectious Diseases and Mycology (11 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Antibiotic Use and Resistance (10 papers) and Nail Diseases and Treatments (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (523 citations), Molecular Medicine (1.1k citations), Infectious Diseases (2.8k citations), Endocrinology (405 citations) and Epidemiology (2.6k citations). Ronen Ben‐Ami has collaborated with scholars based in Israel, United States and China. Frequent co-authors include Dimitrios P. Kontoyiannis, Russell E. Lewis, Yehuda Carmeli, Shiri Navon‐Venezia, David A. Schwartz, Mitchell J. Schwaber, Konstantinos Leventakos, Michael Giladi, Keith S. Kaye and Saul Yedgar. Their work appears in journals such as Clinical Infectious Diseases, Mycoses, Clinical Microbiology and Infection, Journal of Fungi and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.